The results indicate that although PRMT6-mediated RBM39 methylation promoted the growth and metastasis of NSCLC cells, PRMT6 may also play a pro-tumor role through other target proteins when RBM39 is knocked out. This evidence concerns the gene RBM39 and non-small cell lung carcinoma.